March 3, 2026 Experience Anthology chapter 11 restructuring We advised an ad hoc group of creditors on the restructuring
March 2, 2026 Experience Global Eggs investment of up to $1 billion from Warburg Pincus We are advising Global Eggs on the transaction
March 2, 2026 Experience TruArc Partners acquisition of Matrix Adhesives Group We advised TruArc on the transaction
February 13, 2026 Experience Rhône Capital acquisition of Invacare We advised Highbridge Capital, as an Invacare secured lender and noteholder, on the transaction
January 26, 2026 Experience Leidos $2.4 billion acquisition of ENTRUST Solutions Group We are advising Leidos on the transaction
January 20, 2026 Experience AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca We advised AbelZeta on the transaction
January 15, 2026 Experience Delinea acquisition of StrongDM We are advising TPG and Delinea on the transaction
January 15, 2026 Experience Penumbra $14.5 billion sale to Boston Scientific We are advising Penumbra on the transaction
December 22, 2025 Experience TPG acquisition of majority stake in Conservice We are advising TPG on the transaction
December 19, 2025 Experience GSK strategic collaboration with CAMP4 Therapeutics We advised GSK on the transaction